Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -11.811023622 | 1.27 | 1.32 | 1.055 | 670273 | 1.23182322 | CS |
4 | 0.39 | 53.4246575342 | 0.73 | 1.36 | 0.7043 | 867698 | 1.00731555 | CS |
12 | -0.865 | -43.5768261965 | 1.985 | 2.06 | 0.7043 | 869578 | 1.26056418 | CS |
26 | -7.21 | -86.5546218487 | 8.33 | 9.36 | 0.7043 | 740446 | 2.44300416 | CS |
52 | -2.82 | -71.5736040609 | 3.94 | 11.41 | 0.7043 | 696827 | 4.20393762 | CS |
156 | -8.36 | -88.1856540084 | 9.48 | 11.41 | 0.7043 | 377264 | 4.33710218 | CS |
260 | -12.91 | -92.017106201 | 14.03 | 18.42 | 0.7043 | 266112 | 5.38134986 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales